Quantcast
Last updated on April 17, 2014 at 8:59 EDT

Latest Fludeoxyglucose Stories

2011-06-07 06:27:31

(Ivanhoe Newswire) -- PET and CT scans, which shows images of both functional and anatomical changes in the body, are useful for viewing ovarian cancer before any operations are done. Physicians can predict whether a mass is malignant, cancerous but stable, or benign using this method. "We found that PET/CT imaging with the radiotracer 18F-FDG gave us beneficial information about the ovarian cancer stage that helped gynecologists in their treatment planning," Majbritt Frost, research...

2011-05-19 09:00:00

WARRENDALE, Pa., May 19, 2011 /PRNewswire/ -- MEDRAD, INC., a business of Bayer HealthCare, has announced the launch of the next generation Intego(TM) PET Infusion System, which features a new design that is 38% smaller, power-driven and includes enhancements to technologist workflow. The new Intego will be on display at the Annual Meeting of the Society of Nuclear Medicine (SNM), June 4-8, in San Antonio, Texas. (Logo: http://photos.prnewswire.com/prnh/20040309/MEDRADLOGO ) The...

2011-04-29 15:00:59

Combining computerized tomography (CT) with fluorodeoxyglucose positron emission tomography (FDG-PET) images results in significantly more defined tumor outlines and potentially different treatment options in head and neck cancer patients compared to using CT alone, according to research presented today, at the Cancer Imaging and Radiation Therapy Symposium in Atlanta. This symposium is co-sponsored by the American Society for Radiation Oncology (ASTRO) and the Radiological Society of North...

2011-03-02 16:55:39

Greatest Gains Seen in Largest Patients and Shortest Studies For the first time, quantitative"”not qualitative"“ data analysis has demonstrated that time-of-flight (TOF) positron emission tomography (PET) scans can improve cancer detection. Research published in the March issue of The Journal of Nuclear Medicine shows that oncologic TOF fluorodeoxyglucose (FDG) PET scans yielded significant improvements in lesion detection of lung and liver cancers over all contrasts and body mass...

2011-02-14 08:20:00

WEARE, N.H., Feb. 14, 2011 /PRNewswire/ -- RadQual, LLC, a premier developer of innovative quality control products for nuclear medicine, SPECT, and positron emission tomography (PET) imaging, is pleased to announce the only dose calibrator standard directly traceable to the National Institute of Standards and Technology (NIST) for accurate measurement of gallium-68 and fluorine-18 is now available up to a 1 millicurie (37 MBq) strength. Fluorine-18 is an important isotope in the...

2011-01-03 14:28:10

Largely unknown condition leads to devastating outcomes Sudden, catastrophic childhood epilepsy is a parent's worst nightmare, especially in the case of fever-induced refractory epileptic encephalopathy in school-age children (FIRES). While not much is known about the condition, new research published in the January issue of The Journal of Nuclear Medicine shows that positron emission tomography (PET) scans can offer an evaluation of cognitive dysfunction of FIRES, its evolution and further...

2010-12-07 14:12:20

PET/CT scan predicts and detects local recurrence after radiofrequency ablation A study published in the December issue of The Journal of Nuclear Medicine identified positron emission tomography/computed tomography (PET/CT) scans as a potentially useful tool for predicting local recurrence in lung cancer patients treated with radiofrequency ablation (RFA). RFA, which uses localized thermal energy to kill cancer cells, is increasingly used as an alternative treatment for patients unable to...

2010-11-29 08:28:00

WARRENDALE, Pa., Nov. 29, 2010 /PRNewswire/ -- MEDRAD, Inc. a business of Bayer HealthCare, today announces the U.S. launch of VirtualCARE®, for the MEDRAD Intego(TM) PET Infusion System. VirtualCARE is a technology platform that allows MEDRAD to remotely support maintenance and system updates securely over the internet. (Logo: http://photos.prnewswire.com/prnh/20040309/MEDRADLOGO ) MEDRAD is the first company in the U.S. to offer remote service and system support for an...

2010-11-23 04:17:00

BERLIN, November 23, 2010 /PRNewswire-FirstCall/ -- Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), a company specializing in special compounds for the diagnosis and treatment of cancer, via its subsidiary company Eckert & Ziegler f-con Deutschland GmbH closed an exclusive sales agreement with the Karlsruhe-based ZAG Zyklotron AG for the regular delivery of Fluorodeoxyglucose (18F) (FDG). FDG is used in the context of the so called Positron Emission...

2010-10-14 13:42:58

Scientists at the University of Granada  applied successfully a new technique called FDG positron emission tomography scanning, which allows more accurate diagnosis and treatment of Gall bladder cancer. For the purpose of this study, 62 patients were subjected to this scanning method, which represents the largest sample of patients with gall bladder cancer ever studied by applying this type of technology Researchers a the University of Granada and the Department of Nuclear Medicine,...